Compare Amazon.com Inc (AMZN) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amazon.com Inc vs Revvity Inc — how do they compare? Amazon.com Inc trades at $248.37 (market cap $2.64T), while Revvity Inc trades at $111.57 (market cap $12.53B). The key difference: Amazon.com Inc is far larger — about 210.7× Revvity Inc's market cap, and Revvity Inc pays a 0.25% dividend while Amazon.com Inc pays none. Which is the better fit depends on your goals.
| AMZN | RVTY | |
|---|---|---|
Market Cap | $2.64T | $12.53B |
Volume | 3,931,282 | — |
Sector | Consumer Cyclical | Technology |
52-Week High | $274.95 | $117.75 |
52-Week Low | $198.79 | $82.26 |
Enterprise Value | $2.71T | $15.02B |
Dividend Yield | — | 0.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Amazon (AMZN) trades at $248.50, up 1.29% with strong bullish technical momentum. The stock shows robust fundamentals with revenue growing from $514B in 2022 to $716.9B in 2025 and net income surging to $77.7B. Recent Q1 2026 earnings beat expectations at $2.78 EPS versus $1.63 expected. Technical indicators show the stock above key support levels with an overall bullish signal from moving averages.
Amazon presents a compelling investment case with strong revenue growth, expanding profit margins, and dominant market position. Key risks include intense competition in retail and cloud services, high valuation multiples, and significant capital expenditures. Analyst consensus remains overwhelmingly bullish with 88% buy ratings and a $320.75 price target suggesting 29% upside potential.
Revvity (RVTY) trades at $112.29, down 0.58% on the day, with strong technical momentum showing bullish moving averages and key support at $110. The company demonstrates consistent earnings beats with Q1 2026 EPS of $1.06 exceeding expectations, maintaining solid profitability with 54.32% gross margins. Recent developments include AI integration partnerships with Anthropic and FDA clearance for new diagnostic tests, signaling innovation in life sciences.
RVTY presents a mixed outlook with analyst consensus leaning bullish (52% buy ratings) but trading above the $109.38 price target. While strong operational cash flow ($583M in 2025) and AI expansion provide upside potential, elevated P/E ratio (53.99) and declining net cash flow (-$243M in 2025) warrant caution amid competitive pressures in healthcare technology.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amazon.com Inc
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
